These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18804888)

  • 21. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
    Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ADVANCE study begins enrollment.
    AIDS Patient Care STDS; 2008 Apr; 22(4):345. PubMed ID: 18422463
    [No Abstract]   [Full Text] [Related]  

  • 23. Tyranny of algorithms in the treatment of patients with hepatitis C.
    Rubin RA
    Hepatology; 2003 Dec; 38(6):1593-4; author reply 1594-5. PubMed ID: 14647072
    [No Abstract]   [Full Text] [Related]  

  • 24. [PEG-interferons: significance for the treatment of viral hepatitis B and C].
    Wedemeyer H; Cornberg M; Manns MP
    Dtsch Med Wochenschr; 2001 Jun; 126 Suppl 1():S68-75. PubMed ID: 11450618
    [No Abstract]   [Full Text] [Related]  

  • 25. Utility of week-4 viral response to tailor treatment duration in hepatitis C virus genotype 3/HIV co-infected patients.
    Crespo M; Esteban JI; Ribera E; Falco V; Sauleda S; Buti M; Esteban R; Guardia J; Ocaña I; Pahissa A
    AIDS; 2007 Feb; 21(4):477-81. PubMed ID: 17301566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Interferon therapy for chronic hepatitis B].
    Kakumu S
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():315-20. PubMed ID: 15453337
    [No Abstract]   [Full Text] [Related]  

  • 27. [Peginterferon-alpha and ribavirin combination therapy in chronic hepatitis C].
    Han KH; Yoon YH
    Korean J Hepatol; 2004 Jun; 10(2):81-7. PubMed ID: 15218341
    [No Abstract]   [Full Text] [Related]  

  • 28. [Difficult-to-treat patient with chronic hepatitis C: a challenge in clinical practice].
    Dou XG
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):486-7. PubMed ID: 19912678
    [No Abstract]   [Full Text] [Related]  

  • 29. Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.
    Martin-Carbonero L; Nuñez M; Mariño A; Alcocer F; Bonet L; García-Samaniego J; López-Serrano P; Cordero M; Portu J; Soriano V
    AIDS; 2008 Jan; 22(1):15-21. PubMed ID: 18090387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of viral hepatitis in children].
    Jaklin Kekez A
    Acta Med Croatica; 2009 Dec; 63(5):459-62. PubMed ID: 20198908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection.
    Coppola N; Pisapia R; Tonziello G; Martini S; Imparato M; Piai G; Stanzione M; Sagnelli C; Filippini P; Piccinino F; Sagnelli E
    Antivir Ther; 2008; 13(2):307-18. PubMed ID: 18505182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Viral kinetics in the treatment of chronic hepatitis C.
    Layden-Almer JE; Cotler SJ; Layden TJ
    J Viral Hepat; 2006 Aug; 13(8):499-504. PubMed ID: 16901279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pioglitazone as adjuvant therapy in chronic hepatitis C: sequential rather than concomitant administration with pegylated interferon and ribavirin?
    Serfaty L; Fartoux L; Poupon R
    J Hepatol; 2009 Jun; 50(6):1269-71. PubMed ID: 19395115
    [No Abstract]   [Full Text] [Related]  

  • 34. Entering the new era of therapy for HBV and HCV infections.
    Peters MG; Perrillo RP; Jacobson IM; Ross DB; Doo EC; Murray JS; Wong JB
    J Fam Pract; 2010 Apr; 59(4 Suppl):S51-8. PubMed ID: 20398591
    [No Abstract]   [Full Text] [Related]  

  • 35. Peginterferon alfa-2b plus ribavirin for chronic hepatitis.
    Santin M; Shaw E
    Lancet; 2002 Jan; 359(9302):263; author reply 264. PubMed ID: 11812596
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experiences in antiviral treatment of chronic viral hepatitis B and C in Hungary (1998-2004)].
    Pár A; Tornai I; Szalay F
    Orv Hetil; 2007 May; 148(18):819-26. PubMed ID: 17468063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular virology and treatment of patients with chronic hepatitis C].
    Simon K; Szymczak A
    Przegl Epidemiol; 2005; 59(2):503-10. PubMed ID: 16190560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-duration therapy for hepatitis C: suitable for all?
    Mangia A
    J Viral Hepat; 2007 Apr; 14(4):221-7. PubMed ID: 17381713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peginterferon alfa-2b plus ribavirin for chronic hepatitis.
    Cecil BD
    Lancet; 2002 Jan; 359(9302):263-4. PubMed ID: 11812598
    [No Abstract]   [Full Text] [Related]  

  • 40. [Long-term viral response to interferon alpha 2b plus ribavirin in chronic hepatitis C patients during standard therapy].
    Adamek A; Adamek J; Juszczyk J; Bereszyńska I
    Przegl Epidemiol; 2007; 61(4):765-70. PubMed ID: 18572509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.